张浩晨
|01| A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer's Disease NANO LETT, 2024, 24(32): 9906-9915. |02| Polyoxometalates: metallodrug agents for combating amyloid aggregation NATL SCI REV, 2024, 11(7): nwae226. |03| Biomimetic engineering of a neuroinflammation-targeted MOF nanozyme scaffolded with photo-trigger released CO for the treatment of Alzheimer's disease | 关注善思微信公众号 | ||||||||||||||||||||
2 | 0 | 2 | 4 | 0 | 9 | 1 | 9 | 0 | 6 | 4 | 4 | 2 | 8 | 5 | 0 | 1 | 5 | 1 | 9 |